Cargando…

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker

DDX60, an interferon (IFN)-inducible gene, plays a promotional role in many tumors. However, its function in glioma remains unknown. In this study, bioinformatic analysis (TCGA, CGGA, Rembrandt) illustrated the upregulation and prognostic value of DDX60 in gliomas. Immunohistochemical staining of cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jingwen, Fu, Minjie, Zhang, Mengli, Zhang, Jinsen, Du, Zunguo, Zhang, Hongyi, Hua, Wei, Mao, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222729/ https://www.ncbi.nlm.nih.gov/pubmed/34178649 http://dx.doi.org/10.3389/fonc.2021.665360

Ejemplares similares

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

The DEAD-box RNA helicase, DDX60, Suppresses immunotherapy and promotes malignant progression of pancreatic cancer
por: Lai, Tiantian, et al.
Publicado: (2023)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

The Inhibition of B7H3 by 2-HG Accumulation Is Associated With Downregulation of VEGFA in IDH Mutated Gliomas
por: Zhang, Mengli, et al.
Publicado: (2021)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
por: Guo, Qinglong, et al.
Publicado: (2021)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients
por: Zhang, Jiexia, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
por: Zhang, Yu, et al.
Publicado: (2021)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
por: Filley, Anna C., et al.
Publicado: (2018)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2023)

Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC
por: Zhang, Zhimin, et al.
Publicado: (2021)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus
por: Chen, Wu, et al.
Publicado: (2023)

DDX10 and BYSL as the potential targets of chondrosarcoma and glioma
por: Quan, Xuemin, et al.
Publicado: (2021)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis
por: Yuan, Yexin, et al.
Publicado: (2023)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

DDX3X Biomarker Correlates with Poor Survival in Human Gliomas
por: Hueng, Dueng-Yuan, et al.
Publicado: (2015)

Role of Borneol Induced Autophagy in Enhancing Radiosensitivity of Malignant Glioma
por: Li, Qinglin, et al.
Publicado: (2021)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
por: Peng, Xuenan, et al.
Publicado: (2023)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
por: Jin, Shenhe, et al.
Publicado: (2022)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma
por: Fu, Minjie, et al.
Publicado: (2021)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism
por: Wen, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_um87iv5qpfnhk96al6stf23lqb